Potential drawbacks of SARS-CoV-2 seroprevalence surveys.
作者信息
Lippi G
机构信息
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
出版信息
J Hosp Infect. 2021 Apr;110:206. doi: 10.1016/j.jhin.2020.12.011. Epub 2020 Dec 21.
Abstract
摘要
相似文献
1
Potential drawbacks of SARS-CoV-2 seroprevalence surveys.新型冠状病毒2型血清流行率调查的潜在缺点。
J Hosp Infect. 2021 Apr;110:206. doi: 10.1016/j.jhin.2020.12.011. Epub 2020 Dec 21.
2
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.日本东京一家大型国立医院及其附属机构中抗新冠病毒 2 型抗体的血清流行率。
J Infect. 2021 Apr;82(4):e1-e3. doi: 10.1016/j.jinf.2021.01.010. Epub 2021 Jan 29.
3
SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis.北布里斯托尔国民保健服务信托基金医护人员及其他工作人员中新型冠状病毒2型IgG血清流行率：一项社会人口学分析。
J Infect. 2021 Mar;82(3):e24-e27. doi: 10.1016/j.jinf.2020.11.036. Epub 2020 Dec 1.
4
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.日本第二波疫情浪潮后，一家国立医院及其附属机构中SARS-CoV-2抗体的血清阳性率。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.017. Epub 2021 May 25.
5
Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital.一家专科医院中医护人员对新冠病毒的血清阳性率
Indian Pediatr. 2021 Mar 15;58(3):279-280. doi: 10.1007/s13312-021-2170-1.
6
Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal.葡萄牙北部一家肿瘤医院医护人员感染新冠病毒三个月后的抗SARS-CoV-2抗体血清阳性率
Acta Med Port. 2021 Jun 1;34(6):484-485. doi: 10.20344/amp.16336.
7
SARS-CoV-2 seroprevalence in the Vatican City State.梵蒂冈城国的新冠病毒血清流行率。
Eur J Intern Med. 2021 Apr;86:98-99. doi: 10.1016/j.ejim.2021.01.029. Epub 2021 Feb 4.
8
Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.越南南部一家新冠肺炎三级转诊医院的医护人员中未检测到严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体。
J Infect. 2021 Jan;82(1):e36-e37. doi: 10.1016/j.jinf.2020.11.018. Epub 2020 Nov 19.
9
Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.低流行地区医护人员中未被识别的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清流行率。
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1532-1534. doi: 10.1017/ice.2020.1341. Epub 2020 Nov 20.
10
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
引用本文的文献
1
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.用于苏格兰流行病学监测的严重急性呼吸综合征冠状病毒2血清学检测方法比较
J Clin Virol Plus. 2021 Sep;1(3):100028. doi: 10.1016/j.jcvp.2021.100028. Epub 2021 Jun 14.
本文引用的文献
1
Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China.中国武汉近千万居民封控后新冠病毒核酸筛查。
Nat Commun. 2020 Nov 20;11(1):5917. doi: 10.1038/s41467-020-19802-w.
2
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素：系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
3
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2.国际临床化学联合会关于针对 SARS-CoV-2 的抗体血清学检测的临时指南。
Clin Chem Lab Med. 2020 Oct 7;58(12):2001-2008. doi: 10.1515/cclm-2020-1413.
4
Global perspective of COVID-19 epidemiology for a full-cycle pandemic.COVID-19 流行病学的全球视角——全周期大流行。
Eur J Clin Invest. 2020 Dec;50(12):e13423. doi: 10.1111/eci.13423. Epub 2020 Oct 25.
5
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.田纳西州纳什维尔的医护人员中，针对 SARS-CoV-2 的抗体在 60 天内的变化。
JAMA. 2020 Nov 3;324(17):1781-1782. doi: 10.1001/jama.2020.18796.
Zotero 插件